Grandfield & Dodd LLC Takes $1.95 Million Position in Nutrien Ltd. $NTR

Posted by George Bondi on Aug 18th, 2026

Grandfield & Dodd LLC bought a new stake in Nutrien Ltd. (NYSE:NTR – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 30,960 shares of the company’s stock, valued at approximately $1,949,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of NTR. Vanguard Group Inc. grew its position in Nutrien by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 22,463,277 shares of the company’s stock worth $1,386,546,000 after acquiring an additional 479,834 shares during the last quarter. Wellington Management Group LLP increased its position in Nutrien by 440.2% during the 4th quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company’s stock valued at $1,008,713,000 after purchasing an additional 13,313,817 shares during the period. First Eagle Investment Management LLC increased its position in shares of Nutrien by 0.5% during the fourth quarter. First Eagle Investment Management LLC now owns 13,307,283 shares of the company’s stock worth $821,326,000 after buying an additional 70,068 shares during the period. Deutsche Bank AG grew its holdings in Nutrien by 2.0% during the 4th quarter. Deutsche Bank AG now owns 9,798,196 shares of the company’s stock worth $604,745,000 after acquiring an additional 189,683 shares during the period. Finally, TD Asset Management Inc grew its stake in Nutrien by 21.2% during the fourth quarter. TD Asset Management Inc now owns 8,928,534 shares of the company’s stock worth $551,821,000 after purchasing an additional 1,559,673 shares during the period. Institutional investors own 63.10% of the company’s stock.

Nutrien Stock Performance

Nutrien stock opened at $68.33 on Tuesday. The firm has a market capitalization of $32.69 billion, a PE ratio of 13.83, a price-to-earnings-growth ratio of 0.68 and a beta of 0.61. Nutrien Ltd. has a 1-year low of $53.03 and a 1-year high of $85.36. The firm’s 50 day simple moving average is $65.94 and its 200 day simple moving average is $70.37. The company has a current ratio of 1.39, a quick ratio of 0.86 and a debt-to-equity ratio of 0.36.

Nutrien (NYSE:NTR – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The business had revenue of $10.81 billion during the quarter, compared to analysts’ expectations of $10.44 billion. During the same quarter last year, the business posted $2.65 EPS. The company’s quarterly revenue was up 3.6% on a year-over-year basis. As a group, analysts expect that Nutrien Ltd. will post 5.01 earnings per share for the current fiscal year.

Nutrien Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 16th. Stockholders of record on Tuesday, September 29th will be issued a $0.55 dividend. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 annualized dividend and a dividend yield of 3.2%. Nutrien’s dividend payout ratio (DPR) is currently 44.53%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on NTR shares. Oppenheimer reduced their price target on shares of Nutrien from $82.00 to $80.00 and set an “outperform” rating for the company in a report on Thursday, July 23rd. Bank of America upgraded Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price target for the company in a report on Thursday, April 30th. UBS Group reduced their price objective on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a research report on Monday, May 11th. Raymond James Financial raised Nutrien from a “market perform” rating to an “outperform” rating and raised their target price for the company from $74.00 to $90.00 in a research report on Tuesday, May 5th. Finally, TD Securities restated a “buy” rating on shares of Nutrien in a research note on Wednesday, May 6th. Seventeen investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.58.

Read Our Latest Research Report on Nutrien

Nutrien Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.